Emergent BioSolutions (EBS) Prepaid Assets (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Prepaid Assets of $26.9 million for Q1 2026, down 10.93% year-over-year from $30.2 million in Q1 2025, and up 4.26% quarter-over-quarter from $25.8 million in Q4 2025.
Emergent BioSolutions (EBS) Prepaid Assets (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Prepaid Assets history runs 17 years deep, the most recent figure standing at $26.9 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 10.93% year-over-year to $26.9 million; the TTM figure through Mar 2026 stood at $26.9 million (down 10.93% YoY), while the FY2025 annual figure was $25.8 million, down 4.09% from the prior year.
- Prepaid Assets for Q1 2026 stood at $26.9 million, up from $25.8 million in the prior quarter.
- The five-year high for Prepaid Assets was $139.9 million in Q3 2022, with the low at $24.0 million in Q2 2025.
- The 5-year median for Prepaid Assets is $41.7 million (2023), against an average of $52.6 million.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 93.84% in 2022, then sank 64.35% in 2023.
- Emergent BioSolutions' Prepaid Assets stood at $57.9 million in 2022, then retreated by 17.27% to $47.9 million in 2023, then slumped by 43.84% to $26.9 million in 2024, then decreased by 4.09% to $25.8 million in 2025, then gained by 4.26% to $26.9 million in 2026.
- Business Quant data shows EBS's Prepaid Assets at $26.9 million in Q1 2026, $25.8 million in Q4 2025, and $25.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Emergent BioSolutions | 261.35 Mn | 120.45 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.40 Mn |
| Mar 31, 2026 | 26.90 Mn |
| Dec 31, 2025 | 25.80 Mn |
| Sep 30, 2025 | 25.60 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | 30.20 Mn |
| Dec 31, 2024 | 26.90 Mn |
| Sep 30, 2024 | 61.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Mar 31, 2024 | 36.50 Mn |
| Dec 31, 2023 | 47.90 Mn |
| Sep 30, 2023 | 62.40 Mn |
| Jun 30, 2023 | 44.70 Mn |
| Mar 31, 2023 | 41.70 Mn |
| Dec 31, 2022 | 57.90 Mn |
| Sep 30, 2022 | 139.90 Mn |
| Jun 30, 2022 | 125.40 Mn |
| Mar 31, 2022 | 81.80 Mn |
| Dec 31, 2021 | 70.20 Mn |
| Sep 30, 2021 | 88.30 Mn |